Marking the end of a two-decade-long drought, AKLIEF cream is the first Retinoid Molecule that’s been approved for the treatment of acne in over 20 years. The cream is designed to selectively target the most common retinoic acid receptor found in the skin. Giving patients and doctors a much-needed potential treatment option. Learn more about… Read More
We’ve all been there, standing in front of the mirror and all of a sudden something catches your eye. A new brown spot, seemingly appearing out of nowhere, has decided to call your skin it’s new home. No big deal, right? We all have a few moles. Most of the time you’d be correct. Moles… Read More
When it comes to acne medications, there are a plethora of options available for both oral and topical treatments. Each option has Its own benefits and side effects, making the importance of proper research and education a key step in identifying the best possible treatment for your unique situation. Follow the link below to learn… Read More
AbbVie, a research-based global biopharmaceutical company, announced that the FDA approved SKYRIZI™ for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Read the full announcement by AbbVie.
Read more about FDA Approves New Topical Treatment for Atopic Dermatitis
Read about advances in Serborrheic Keratosis on the Global Academy for Medical Education website.
Five common pitfalls of retailing skin care
FDA Approves OLUMIANT® (baricitinib) 2-mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis- click HERE to read more!
Could New CBD Cream Could Be Ultimate Cure For Acne?
Psoriasis is not a cosmetic problem. Nearly 60 percent of people with psoriasis reported their disease to be a large problem in their everyday life. DS Research is currently conducting various research studies for the treatment of plaque psoriasis as well as itching that is associated with psoriasis. To learn more about these statistics involving… Read More